Quantcast

Latest Opioid Stories

2014-02-05 08:29:57

CORALVILLE, Iowa, Feb. 5, 2014 /PRNewswire/ -- KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today that president and CEO, Travis Mickle, Ph.D., will present at the 16(th) Annual BIO CEO & Investor Conference. Hosted by the Biotechnology Industry Organization (BIO), the 16(th) Annual BIO CEO & Investor Conference will take place February 10-11 at the Waldorf Astoria in New...

2014-02-03 23:01:07

In response to the death of Philip Seymour Hoffman on February 2, 2014 and questions about heroin abuse amongst the impaired professional, The Farley Center at Williamsburg Place, the nation's leading addiction treatment center for the impaired professional, has offered to provide expert consultation. Dr Jonathan C. Lee, M.D., Associate Medical Director for the Farley Center is one of a handful of physicians highly experienced in this area. (PRWEB) February 03, 2014 As initially...

2014-01-30 08:30:48

First presentation of detailed BUNAVAIL clinical data scheduled for April 11 and 13, 2014 RALEIGH, N.C., Jan. 30, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) today announced that data from clinical studies of BUNAVAIL have been accepted for presentation at the American Society of Addiction Medicine (ASAM) 45(th) Annual Medical-Scientific Conference, April 10-13, 2014 in Orlando, Florida. (Logo:...

2014-01-23 16:25:23

MALVERN, Pa. and RALEIGH, N.C., Jan. 23, 2014 /PRNewswire/ -- Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc. (Nasdaq: ENDP), and BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced today positive top-line results from its pivotal Phase 3 efficacy study of BEMA buprenorphine in opioid- "naive" subjects. BEMA buprenorphine is being developed for the treatment of moderate to severe chronic pain in patients requiring around-the-clock opioid therapy for...

2014-01-16 16:23:41

DUBLIN, January 16, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/sqmftt/pain_therapeutics) has announced the addition of a new report "Pain Therapeutics - Drugs, Markets and Companies" [http://www.researchandmarkets.com/research/sqmftt/pain_therapeutics ] to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This report describes the latest concepts of pathomechanisms of pain as a basis...

Scientists Solve Mystery Of How Sodium Controls Opioid Brain Signaling
2014-01-13 07:13:26

Scripps Research Institute The findings pave way for new therapies for treating pain and mood disorders Scientists have discovered how the element sodium influences the signaling of a major class of brain cell receptors, known as opioid receptors. The discovery, from The Scripps Research Institute (TSRI) and the University of North Carolina (UNC), suggests new therapeutic approaches to a host of brain-related medical conditions. "It opens the door to understanding opioid related...

2014-01-09 12:26:30

CORALVILLE, Iowa, Jan. 9, 2014 /PRNewswire/ -- KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today that president and CEO, Travis Mickle, Ph.D. will present at the Biotech Showcase(TM) 2014 Conference being held in San Francisco January 13-15, 2014. Among the topics to be discussed, Dr. Mickle will provide an overview of KemPharm's development pipeline, including KP201, the...

2014-01-07 23:24:28

Workers' Compensation claims professionals can download a practical, easy-to-use reference on opioid case planning at http://www.healthesystems.com/rxinformer. The piece divides pain into three phases and makes recommendations concerning use of opioids in each. Tampa, FL (PRWEB) January 07, 2014 Workers' Compensation claims professionals can download a practical, easy-to-use reference on opioid case planning at http://www.healthesystems.com/rxinformer. The piece divides pain into...

2014-01-04 23:24:08

Aid in Recovery released a statement today commenting on a recent study into the effectiveness of Naltrexone in treating addiction to opioids. Aid in Recovery has said that it will stay abreast of all clinical research regarding this drug, in order to better serve their patients. West Palm Beach, Florida (PRWEB) January 03, 2014 Aid in Recovery released a statement today commenting on recent research into the effectiveness of the drug Nalltrexone in the treatment of opiod addiction. The...


Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related